People who had mild COVID-19 have long-lasting antibody protection, according to a study by researchers from Washington University School of Medicine in St. Louis. Scientists found that individuals who have recovered from a mild case of COVID-19 have long-lived plasma cells in their bone marrow that secretes low levels of antibodies against the CCP (Chinese…
Research Suggests Mild COVID-19 Illness Leaves Behind Lasting Antibody Protection
Elderly Show Similar Antibody Response to 1st Dose of AstraZeneca, Pfizer COVID-19 Shots: UK Study
LONDON—The first study to directly compare immune reactions between Pfizer’s and AstraZeneca’s COVID-19 vaccines found strong and broadly similar antibody responses in over-80-year-olds after a first dose of either shot, scientists said on Wednesday. The UK study also found that a critical component of the immune system known as T cells showed a more enhanced…
Get Used to Annual Revaccination Against COVID-19, Boris Johnson Says
People will have to get used to the idea of annual revaccination against the CCP virus as new variants emerge, British Prime Minister Boris Johnson said on Wednesday. “I think we’re going to have to get used to the idea of vaccinating and then re-vaccinating in the autumn as we come to face these new…
UK Identifies 2 More COVID-19 Variants With Antibody-Resistant Mutation
British health authorities have identified two more COVID-19 variants with a mutation that makes them resistant to antibodies. Over 4,000 variants of the CCP (Chinese Communist Party) virus, also known as SARS-CoV-2 or the novel coronavirus, have been identified across the globe, most of which are not of concern, the Public Health England (PHE) said….
Regeneron: Antibody Cocktail 100 Percent Effective Against Symptomatic COVID-19 Infections
Regeneron Pharmaceuticals on Tuesday announced that a phase 3 trial still in progress of an antibody cocktail has shown a 100 percent prevention of symptomatic COVID-19 infections. Interim results also show approximately 50 percent lower overall rates of infection across all patients. For infections that did take place, peak virus levels were decreased and they…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`